Evidence map›Paper›PMID 36906051›Full record

ArticleThe journal of pain2023

CpG Methylation Levels in HPA Axis Genes Predict Chronic Pain Outcomes Following Trauma Exposure.

Erica M Branham, Samuel A McLean, Ishani Deliwala, Matthew C Mauck, Ying Zhao, Lauren A McKibben, Aaron Lee, Alex B Spencer, Anthony S Zannas, Megan Lechner and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The journal of pain, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Erica M BranhamInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina; Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, North Carolina.
Samuel A McLeanInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina; Department of Emergency Medicine, University of North Carolina, Chapel Hill, North Carolina.
Ishani DeliwalaInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina.
Matthew C MauckInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina.
Ying ZhaoInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina.
Lauren A McKibbenInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina.
Aaron LeeInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina.
Alex B SpencerInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina.
Anthony S ZannasInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina; Carolina Stress Initiative, University of North Carolina, Chapel Hill, North Carolina.
Megan LechnerForensic Nursing Program, Memorial Health System, Colorado Springs, Colorado.
Teresa DanzaForensic Nursing Program, Albuquerque SANE Collaborative, Albuquerque, New Mexico.
Marc-Anthony VelillaDepartment of Emergency Medicine, Sinai Grace Hospital, Detroit, Michigan.
Phyllis L HendryDepartment of Emergency Medicine, University of Florida College of Medicine, Jacksonville, Florida.
Claire PearsonDepartment of Emergency Medicine, Detroit Receiving, Detroit, Michigan.
David A PeakDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Jeffrey JonesDepartment of Emergency Medicine, Spectrum Health Butterworth Campus, Grand Rapids, Michigan.
Niels K RathlevDepartment of Emergency Medicine, University of Massachusetts Chan Medical School Baystate, Springfield, Massachusetts.
Sarah D LinnstaedtInstitute for Trauma Recovery, University of North Carolina, Chapel Hill, North Carolina; Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina; Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, North Carolina. Electronic address: sarah_linnstaedt@med.unc.edu.
University of North Carolina at Chapel Hill · USDetroit Receiving Hospital · USMassachusetts General Hospital · USMemorial Health System · USSinai Grace Hospital · USSpectrum Health · USUniversity of Florida · USUniversity of Massachusetts Chan Medical School · US

Funding

NRSA in GeneticsT32GM135128 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Daniel J McKay, JEFF J. SEKELSKY · 2020 to 2026
$5.1M
Applying Biopsychosocial Model to Post-MVC Pain Development in African AmericansR01AR060852 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MCLEAN, SAMUEL A. · 2011 to 2015
$3.6M
Influence of PTSD Symptoms on Chronic Pain Development after Sexual AssaultR01AR064700 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MCLEAN, SAMUEL A. · 2014 to 2018
$3.6M
FKBP51 antagonism to prevent chronic pain: optimizing efficacy & evaluating safety and mechanismsR01NS118563 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LINNSTAEDT, SARAH, MCLEAN, SAMUEL A. · 2020 to 2024
$3.4M
Key Molecular Mechanisms of Chronic Pain Vulnerability in Women Experiencing MVCK01AR071504 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LINNSTAEDT, SARAH · 2018 to 2021
$502k
NIAMS NIH HHS K01 AR071504NIAMS NIH HHS R01 AR060852NIAMS NIH HHS R01 AR064700NIGMS NIH HHS T32 GM135128NINDS NIH HHS R01 NS118563
6 · The paper itself

Abstract

Chronic post-traumatic musculoskeletal pain (CPTP) is a common outcome of traumatic stress exposure. Biological factors that influence the development of CPTP are poorly understood, though current evidence indicates that the hypothalamic-pituitary-adrenal (HPA) axis plays a critical role in its development. Little is known about molecular mechanisms underlying this association, including epigenetic mechanisms. Here, we assessed whether peritraumatic DNA methylation levels at 248 5'-C-phosphate-G-3' (CpG) sites in HPA axis genes (FKBP5, NR3C1, CRH, CRHR1, CRHR2, CRHBP, POMC) predict CPTP and whether identified CPTP-associated methylation levels influence expression of those genes. Using participant samples and data collected from trauma survivors enrolled into longitudinal cohort studies (n = 290), we used linear mixed modeling to assess the relationship between peritraumatic blood-based CpG methylation levels and CPTP. A total of 66 (27%) of the 248 CpG sites assessed in these models statistically significantly predicted CPTP, with the three most significantly associated CpG sites originating from the POMC gene region (ie, cg22900229 [β = .124, P < .001], cg16302441 [β = .443, P < .001], cg01926269 [β = .130, P < .001]). Among the genes analyzed, both POMC (z = 2.36, P = .018) and CRHBP (z = 4.89, P < .001) were enriched in CpG sites significantly associated with CPTP. Further, POMC expression was inversely correlated with methylation levels in a CPTP-dependent manner (6-months NRS<4: r = -.59, P < .001; 6-months NRS ≥ 4: r = -.18, P = .2312). Our results suggest that methylation of HPA axis genes including POMC and CRHBP predict risk for and may contribute to vulnerability to CPTP. PERSPECTIVE: Peritraumatic blood levels of CpG methylation sites in HPA axis genes, particularly CpG sites in the POMC gene, predict CPTP development. This data substantially advances our understanding of epigenetic predictors and potential mediators of CPTP, a highly common, morbid, and hard-to-treat form of chronic pain.

Indexed as

Chronic PainHypothalamo-Hypophyseal SystemDNA MethylationHumansLongitudinal StudiesPituitary-Adrenal SystemPro-OpiomelanocortinPro-OpiomelanocortinHPA axisMethylationpainPOMCtrauma

Identifiers

PMID36906051
PMCPMC10330094
OpenAlexW4323863122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.